Key result
Ambulatory blood pressure variability may be an independent predictor of hypertensive target organ damage and cardiovascular events, though its clinical impact requires further prospective studies.
Answers are grounded in this paper and cite their sources.
Ambulatory blood pressure variability represents a potential additional axis for cardiovascular risk stratification alongside absolute blood pressure levels and target organ damage.
There is consensus that an increased blood pressure (BP) level increases the risk for cardiovascular disease. The ambulatory BP level during a 24-h period is more closely associated with advanced hypertensive target organ damage and a poorer cardiovascular prognosis than the clinic BP level. On the other hand, the clinical implication of ambulatory BP variability has not been established as an independent cardiovascular risk predictor.1 Some studies have found that ambulatory BP variability is a significant and independent determinant of target organ damage,2,3 and poor cardiovascular prognosis, whereas other investigators have not found an independent association.4 In population studies, 24-h BP variability and daytime BP variability have been independently associated with left ventricular hypertrophy3 and cardiovascular mortality,4 respectively. Recently, Gómez-Angelats et al5 demonstrated that in middle-aged untreated hypertensive patients, ambulatory systolic BP variabilities (SD of 24-h BP) assessed by intermittent ambulatory BP monitoring and by noninvasive continuous (beat-to-beat) BP monitoring were significantly associated with brain deep white matter lesion detected by brain magnetic resonance imaging. This deep white matter lesion, a silent cerebral disease, is a predisposing condition of clinical stroke, dementia, depression, and falls in the elderly.6 In older subjects, increased ambulatory systolic BP variability was also significantly associated with brain atrophy.7 The two major determinants of BP variability are age and a high BP level, which are also major cardiovascular risk factors. Thus, the significant impact of BP variability on cardiovascular disease seems to depend partly on age and high BP level. In fact, in a previous study, the significant association between BP variability and cardiovascular risk disappeared after controlling for confounding factors including age and ambulatory BP level.4 In the study by Gómez-Angelats et al,5 after adjusting for 24-h BP level, the positive association between BP variability and deep white matter lesion disappeared. The 24-h ambulatory BP variability includes behavior-induced BP changes8,9 and specific components of diurnal BP variation, which is a potential risk for cardiovascular disease (Fig. 1).10–16 These specific components may be more closely associated with hypertensive target organ damage and subsequent cardiovascular events than overall 24-h ambulatory BP variability. Abnormal diurnal BP variation, such as marked nocturnal BP decreases (extreme dippers)10,11 or exaggerated morning BP surge,12–14 and reverse diurnal BP variation patterns with higher sleep BP than awake BP (risers), are risks for target organ damage and cardiovascular events. These phenotypes of ambulatory BP variability are associated with each other and with 24-h ambulatory BP variability.14,15 Abnormal diurnal BP variability is associated with other relatively shorter BP variability such as orthostatic BP variability in elderly hypertensives.15 Various mechanisms may be involved in the association between BP variability and cardiovascular disease. In addition to augmented mechanical stress on the cardiovascular system (which leads to cardiovascular remodeling), increased variability of blood flow by augmented BP variability increases sheer stress on endothelial cells advancing atherosclerosis. Sheer stress-induced platelet activation at atherosclerotic stenotic sites,17 and subsequent hypercoagulability may lead to cardiovascular events. Neurohumoral activation, which is increased in those with increased BP variability,18 may also increase the risk for cardiovascular disease. Clinically, current cardiovascular risk stratification depends on the ambulatory BP level and the status of the target organ damage. In addition to these two major predictors, BP variability may be the possible third axis of risk stratification. Development of a BP monitoring device to detect the specific component of BP variability, reproducibility, and further prospective and interventional studies are necessary to establish the clinical impact of BP variability on target organ damage and cardiovascular events in hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Kazuomi Kario (2004) conducted a review in Hypertension and cardiovascular disease. Ambulatory blood pressure variability was evaluated. Ambulatory blood pressure variability may be an independent predictor of hypertensive target organ damage and cardiovascular events, though its clinical impact requires further prospective studies.
Synapse has enriched 10 related papers. Consider them for comparative context: